ADITXTREPROGRAMMING
Dead / Abandoned — Abandoned — no statement of use filed (as of 26 Feb 2024)
What this means for you
This application is over — abandoned 26 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90062170
- Mark type
- Stylized text
- Filed
- 20 Jul 2020
- Published for opposition
- 25 May 2021
- Abandoned
- 26 Feb 2024
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and therapeutic agents modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance
- Class 042 — Scientific and technological services: Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research
- Class 044 — Medical, beauty and agricultural services: Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health
Owner
- ADITXT, INC., Richmond, VA, US
- Aditx Therapeutics, Inc., Mountain View, CA, US
- Aditx Therapeutics, Inc., Mountain View, CA, US
Prosecution history
- 26 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 26 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 19 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2023 — SOU EXTENSION 4 GRANTED
- 17 Jul 2023 — SOU EXTENSION 4 FILED
- 17 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2023 — SOU EXTENSION 3 GRANTED
- 17 Jan 2023 — SOU EXTENSION 3 FILED
- 17 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Jul 2022 — SOU EXTENSION 2 GRANTED
- 18 Jul 2022 — SOU EXTENSION 2 FILED
- 18 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 23 Mar 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED